Active Biotech AB | Ownership
Companies that own Active Biotech AB
Tredje AP-fonden
3,893,722
2.68%
441,288
0.01%
06/29/2018
Fjärde AP-fonden
3,167,559
2.18%
438,790
0.01%
06/29/2018
Rhenman & Partners Asset Management AB
1,274,022
0.88%
-75,164
0.04%
12/31/2017
SEB Investment Management AB
1,160,168
0.8%
1,160,168
0%
03/29/2018
Nordea Investment Management AB
1,051,473
0.72%
42,150
0%
05/31/2018
Max Mitteregger Kapitalförvaltning AB
665,159
0.46%
665,159
0.07%
12/31/2016
Danske Bank A/S (Investment Management Sweden)
67,368
0.05%
0
0%
09/11/2018
Catella Fondförvaltning AB
31,009
0.02%
0
0%
08/31/2018
Macquarie Investment Management Business Trust
19,382
0.01%
6,490
0%
03/31/2018
Semper Constantia Privatbank AG
14,206
0.01%
-843
0%
04/30/2016
| Address |
Scheelevägen 22
Lund SN 223 63
Sweden
|
|
Employees
|
- |
| Website |
http://www.activebiotech.com |
| Updated |
07/08/2019 |
| Active Biotech AB develops pharmaceutical preparations. It develops pharmaceutical products within medical areas where the immune defense is of significant importance, including neurodegenerative diseases, autoimmune, inflammatory disease and various forms of cancer. The company's project portfolio comprises small, orally active immunomodulatory molecules as well as antibody-based immunotherapy. |
